Osmotica Pharmaceuticals Plc Profit Margin

The latest profit margin for OSMT is -1.85% as of June 2023. That compares with -1.62% in the prior-year period — down 14.4% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Osmotica Pharmaceuticals Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, OSMT's profit margin moved from -1.62% to -1.85% — a 14.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Osmotica Pharmaceuticals Plc's valuation or profitability profile.

Against Healthcare companies, OSMT currently prints -1.85% for profit margin, while the sector average sits near 15.58%. That is roughly 1286.5% below the sector mean. Large gaps often invite a closer look at Osmotica Pharmaceuticals Plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Osmotica Pharmaceuticals Plc converts resources into returns. At -1.85%, OSMT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.62% in the prior-year period — down 14.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OSMT's profit margin (-1.85%), review year-over-year change from -1.62%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.